Magellan Rx Pharmacists Explore the Payer Perspective on Oncology Biosimilars
April 18th 2021Rebecca Borgert, PharmD, BCOP, and Jim Rebello, PharmD, from Magellan Rx Management talk about how market trends, payer formulary decisions, and international successes are shaping today's biosimilars industry.
Joseph Alvarnas, MD, Discusses Biosimilar Use at City of Hope
March 10th 2021Joseph Alvarnas, MD, a recent presenter at the Association of Community Cancer Centers annual meeting, discussed efforts to implement biosimilars at City of Hope, a clinical research center, hospital, and graduate medical school in Duarte, California.